Status:
UNKNOWN
Iraqi Trial for Lung Cancer Screening
Lead Sponsor:
Oncology Teaching Hospital, Baghdad
Conditions:
Lung Cancer
Eligibility:
All Genders
50-75 years
Phase:
NA
Brief Summary
Lung cancer is a global problem. Worldwide, 1.2 million people die of lung cancer each year. In Iraq, lung cancer is the most common malignancy after breast cancer and the leading cause of cancer-rela...
Detailed Description
Background Lung cancer is a global problem. Worldwide, 1.2 million people die of lung cancer each year. In Iraq, lung cancer is the most common malignancy after breast cancer and the leading cause of ...
Eligibility Criteria
Inclusion
- male or female
- aged between 50 and 75
- smokers or ex-smoker
- tobacco exposure of more than 30 pack-years
Exclusion
- History of cancer within the last 5 years other than non-melanoma skin cancer or carcinoma in situ,
- heart or respiratory severe co-morbidity with contraindications to thoracoscopy
Key Trial Info
Start Date :
June 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2022
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04366661
Start Date
June 1 2018
End Date
April 1 2022
Last Update
March 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oncology Teaching Hospital
Baghdad, Iraq